Clinical Trial Results: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating short-term survival of acute-on-chronic liver failure patients treated with plasma exchange using 5% human serum albumin; study termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• On Chronic Liver Failure

Drugs mentioned

• Plasma exchange with human serum albumin 5% (human serum albumin 5% (plasma exchange))

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Acute-On-Chronic Liver Failure | Phase 3 | Status: TERMINATED | Results posted: 2026-06-04